|
QUEST has the following research studies open in the Metro Detroit Area:
Paradyse Study
This study will evaluate the safety and effectiveness of an experimental therapy for Parkinson's Disease. Patients must have been taking Levadopa for approximately two years or longer. This study requires nine visits to QUEST over a 14 week period. Patients may be compensated up to $480 for their time and travel. Patients completing this study may also be eligible to receive the experimental therapy for an extended time period at no cost to assess long term benefits.
|
|
|
Randomized Phase II Study
This study evaluates an experimental therapy compared to Sinemet for Parkinson's patients currently taking Sinemet four times a day and experiencing off times. This study requires 13 visits to QUEST and 2 of those visits require 2 overnight stays. Compensation can be up to $2300 for participants' time and travel.
Settle Study
This study evaluates an experimental therapy as an "add-on" medication for Parkinson's patients currently taking Sinemet and experiencing “OFF” times in between doses. The study requires 11 visits to QUEST and compensation can be up to $750 for participants' time and travel.
Phase Two PD Study
This study evaluates a long-acting experimental therapy compared to Stalevo for Parkinson's patients currently taking Stalevo or Comtan. This study requires seven visits over 11 weeks and compensation can be up to $950 for participants’ time and travel.
Patients completing the Phase Two Study may be eligible to receive the experimental therapy for an additional nine months at no cost to assess long term benefits. This extension would require additional visits and patients can be compensated up to $400 for their time and travel.
If you or someone you care about can benefit from participating in a clinical research study, find out more by contacting us.
|
